Valuation Takeda Pharmaceutical Company Limited NYSE

Stocks

TAK

US8740602052

Pharmaceuticals

Market Closed - NYSE 20:00:03 28/10/2026 GMT			Pre-market 13:08:24
20.15 ^USD	-0.59%		19.96	-0.97%

11:52am	Takeda Pharmaceutical Company Limited, Q2 2027 Earnings Call, Oct 29, 2026
10:28am	Takeda Pharmaceutical Posts Higher H1 Attributable Net Profit; Revenue Up	MT

Company Valuation: Takeda Pharmaceutical Company Limited

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	5,423,454	6,762,204	6,564,378	6,749,675	8,948,061	10,070,757	-	-
Change	-	24.68%	-2.93%	2.82%	32.57%	12.55%	-	-
Enterprise Value (EV) ¹	8,919,170	10,611,015	10,950,330	10,725,175	5,130,461	13,978,160	13,775,544	13,471,149
Change	-	18.97%	3.2%	-2.06%	-52.16%	172.45%	-1.45%	-2.21%
P/E	23.8x	21.3x	45.4x	64.6x	46.4x	50x	31.7x	25.8x
PBR	0.95x	1.06x	0.9x	1x	1.2x	1.35x	1.35x	1.34x
PEG	-	0.5x	-0.8x	-2.5x	0.6x	14.44x	0.6x	1.1x
Capitalization / Revenue	1.52x	1.68x	1.54x	1.47x	1.99x	2.14x	2.1x	2.04x
EV / Revenue	2.5x	2.63x	2.57x	2.34x	1.14x	2.97x	2.87x	2.74x
EV / EBITDA	8.54x	9.19x	11.6x	9.71x	4.54x	10.9x	9.95x	9.32x
EV / EBIT	19.4x	21.6x	51.1x	31.3x	12.6x	29.7x	22.8x	19.3x
EV / FCF	8.92x	28.7x	43.4x	15.5x	8.14x	19.8x	19.7x	18.3x
FCF Yield	11.2%	3.49%	2.31%	6.43%	12.3%	5.04%	5.09%	5.45%
Dividend per Share ²	180	180	188	196	200	204.3	208.4	215.8
Rate of return	5.15%	4.14%	4.49%	4.44%	3.53%	3.24%	3.3%	3.42%
EPS ²	147.1	204.3	92.09	68.36	122	126.2	198.9	244.4
Distribution rate	122%	88.1%	204%	287%	164%	162%	105%	88.3%
Net sales ¹	3,569,006	4,027,478	4,263,762	4,581,600	4,505,700	4,701,837	4,795,879	4,925,220
EBITDA ¹	1,043,995	1,154,905	942,077	1,103,982	1,129,888	1,283,280	1,384,870	1,445,085
EBIT ¹	460,844	490,505	214,100	342,600	408,800	469,869	603,713	699,373
Net income ¹	230,059	317,017	144,067	107,900	191,800	196,331	323,029	384,410
Net Debt ¹	3,495,716	3,848,811	4,385,952	3,975,500	-3,817,600	3,907,403	3,704,786	3,400,392
Reference price ²	3,498.00	4,350.00	4,184.00	4,413.00	5,664.00	6,307.00	6,307.00	6,307.00
Nbr of stocks (in thousands)	1,550,444	1,554,530	1,568,924	1,529,498	1,579,813	1,596,759	-	-
Announcement Date	11/05/22	11/05/23	09/05/24	08/05/25	13/05/26	-	-	-

¹JPY in Million²JPY

Estimates

P/E, Detailed evolution

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	37.84x	13.27x	28.43x	0.53%	1,148B
JOHNSON & JOHNSON	39.67x	6.67x	18.75x	1.97%	652B
ABBVIE INC.	37.4x	8.39x	17.35x	2.4%	505B
ROCHE HOLDING AG	21.45x	5.21x	12.93x	2.51%	384B
MERCK & CO., INC.	102.73x	5.76x	24.72x	2.42%	348B
NOVARTIS AG	21.89x	5.76x	13.88x	2.85%	294B
ASTRAZENECA PLC	22.21x	4.49x	12.82x	1.97%	264B
AMGEN INC.	28.66x	7.33x	13.12x	2.23%	244B
GILEAD SCIENCES, INC.	-45.79x	7.11x	27.55x	2.07%	197B
Average	29.56x	7.11x	18.84x	2.11%	448.57B
Weighted average by Cap.	35.29x	8.40x	20.64x	1.79%